RecruitingAlcohol Use DisorderAlcohol-associated Liver Disease
Implementation Facilitation Pilot for Alcohol Use Disorder (AUD) in Alcohol-associated Liver Disease (ALD)
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The goal of this project is to improve provision of integrated medications for alcohol use disorder (MAUD) with brief counseling for patients with alcohol use disorder (AUD) and alcohol-associated liver disease (ALD) in hepatology clinics. There are many benefits of AUD treatment among patients with AUD and ALD such as reduction in liver-related complications and hepatology clinicians providing this care in an integrated fashion can improve access and uptake.
Sponsor: Yale University
You may qualify if…
- ✓ Must provide care for patients with liver disease at a hepatology clinical location within the Yale School of Medicine and YNHH medical system.
You may not qualify if…
- ✕ Providers who do not treat patients with chronic liver disease and alcohol-associated liver disease.
Where it's recruiting
Connecticut
New Haven
Source: ClinicalTrials.gov · NCT07525258 · last updated 2026-05-07